Month: August 2021

SANTA ANA, Calif., Aug. 18, 2021 (GLOBE NEWSWIRE) — Unrivaled Brands, Inc. (OTCQX:UNRV) (“Unrivaled” or the “Company”) announced that it has entered into an exclusive agreement with Feel Better LLC (Feel Better) and their licensing and production partner Halo Collective Inc (Halo). As part of the agreement, Unrivaled will be the exclusive distributor of Feel Better’s FlowerShop* branded products, a cannabis lifestyle and wellness brand, in more than 400 retail stores across California. Founded by Isaac Muwaswes, Gabriel Garcia, and G-Eazy, FlowerShop* complements Unrivaled’s existing distribution lineup of Korova, Sticks, Habit Labs, Cabana, and Serra products by offering a uniquely packaged lifestyle brand with an extensive marketing presence in California. The product lineup includes the FlowerShop* BUDVASE...

Q2 2021 TransUnion Industry Insights Report explores credit trendsCII Levels Through the Past DecadeCredit Industry IndicatorCHICAGO, Aug. 18, 2021 (GLOBE NEWSWIRE) — The financial services industry is rebounding strongly from the early impacts of the COVID-19 pandemic, according to TransUnion’s (NYSE: TRU) Q2 2021 Quarterly Credit Industry Insights Report (CIIR). The auto, credit card, mortgage and personal loan industries exhibited renewed signs of strength at the mid-point of 2021. In the initial months of the pandemic, many lenders struggled with making credit available to consumers in the face of branch closures and a remote workforce. One year later, lenders have adapted and shifted to a digital-first origination strategy and enhanced their capabilities to originate new accounts virtually. Signs of this...

NEW YORK and SYDNEY, Australia, Aug. 18, 2021 (GLOBE NEWSWIRE) — Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise, announced that PENAO Pty Ltd, its majority-owned, Sydney-based anti-cancer drug development company, has signed a drug manufacture contract with Aurigene Pharmaceutical Services, India, a subsidiary of Dr Reddy’s Laboratories Limited (NYSE: RDY; BSE: 500124). This next-generation adenine nucleotide translocase (ANT) inhibitor, PENAO, was shown to be safe and well-tolerated in a phase I clinical trial conducted in Australia where encouraging efficacy data was observed. In a second clinical trial to commence H1 2022, PENAO is planned to be administered as twice-weekly injections to patients with advanced solid tumors. It is going to be a dose-finding study...

CAMBRIDGE, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) — Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, announced today it has appointed Lini Pandite, MBChB, MBA to its board of directors. As a board-certified oncologist and current Chief Medical Officer at Shattuck Labs, Dr. Pandite brings extensive expertise in oncology drug development and clinical application, diversifying the breadth of expertise represented on the board. “Lini’s experience will be highly relevant and complementary on our board, as she has led development of numerous novel oncology medicines over the course of her industry career and treated patients for more than a decade,” said Douglas E. Williams, Ph.D., President and Chief Executive...

ATLANTA, Aug. 18, 2021 (GLOBE NEWSWIRE) — DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of innovative healthcare research, services, and solutions to federal agencies, today announced that it has been awarded a contract by the Centers for Disease Control and Prevention’s (“CDC”) Division of HIV Prevention (“DHP”) Data Management Services through data management and analysis, health informatics, and research support. The contract includes a base period of one year, with four one-year options, for a total value of $35 million. “We are thrilled to partner with DHP in support of their vision of a ‘future free of HIV,’” said Jeanine Christian, President of DLH’s Public Health & Scientific Research operating unit. “This contract extends DLH’s legacy in HIV research across the globe. We are proud...

Company announcement 10-2021, 18 August 2021 Tom Knutzen, Vice Chairman of the Board, has purchased 5,000 shares and consequently has a total shareholding of 25,000 shares.Contacts Media RelationsRasmus Windfeld, +45 40 44 60 60, rwin@flsmidth.com Investor RelationsNicolai Mauritzen, +45 30 93 18 51, nicm@flsmidth.comFLSmidth provides sustainable productivity to the global mining and cement industries. We deliver market-leading engineering, equipment and service solutions that enable our customers to improve performance, drive down costs and reduce environmental impact. Our operations span the globe and our close to 12,000 employees are present in more than 60 countries. In 2019, FLSmidth generated revenue of DKK 20.6 billion. www.flsmidth.comAttachmentCompany announcement 10 2021 Insider Trading

Frank Barbarino, CAIA, will lead fund origination and structuring; Amoy Chambers joins as head of legal for structuring and distribution SINGAPORE, Aug. 18, 2021 (GLOBE NEWSWIRE) — Triterras Inc. (Nasdaq: TRIT, TRITW) (“Triterras” or the “Company”), a leading fintech company focused on trade and trade finance, today announced appointing two management executives, as the company continues to accelerate the global availability of Kratos, its digital trade and trade finance platform, to lenders and capital providers worldwide. Frank Barbarino has joined Triterras as Americas Head, Funds Origination & Structuring. He will work closely with Triterras’ clients—institutional investors, including investment managers and asset owners— in structuring deals and deploying capital to trade finance. With more than two decades of experience...